June 2014 - Page 3 of 5 - 1-800-PublicRelations "1800pr"

18 Jun

SMTP, Inc. CEO Jon Strimling to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 12:05pm MDT / 2:05pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba

NASHUA, NH–(Apr 8, 2014) – SMTP, Inc. (NASDAQ: SMTP), a global provider of email delivery services, today announced that CEO Jon Strimling will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Tuesday, April 8, 2014
Start Time: 11:05am PDT | 12:05pm MDT | 2:05pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s “The Traders Network Show.”

About SMTP, Inc: SMTP is a leading provider of services to facilitate email delivery, with a focus on marketing email delivery, but also supporting bulk and transactional sending, reputation management, compliance auditing, abuse processing and issue resolution. Our services provide customers with the ability to increase the deliverability of email with less time, cost and complexity than handling it themselves.

SMTP, Inc. is a dividend-paying, publicly-traded company headquartered in Las Vegas, Nevada, and can be found on the web at http://www.smtp.com.

Safe Harbor Statement

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words “may,” “will,” “should,” “plans,” “explores,” “expects,” “anticipates,” “continues,” “estimates,” “projects,” “intends,” and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing new customer offerings, changes in customer order patterns, changes in customer offering mix, continued success in technological advances and delivering technological innovations, delays due to issues with outsourced service providers, and various other factors beyond the Company’s control.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Email Delivery, Jon Strimling, Public Relations, SMTP, SMTP Inc Comments Off Read more...

18 Jun

FluoroPharma CEO Thijs Spoor to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 2:05pm EDT / 12:05 pm MDT / 11:05am PDT on The Traders Network Radio Show, Hosted by Michael Yorba

MONTCLAIR, NJ–(Apr 2, 2014) – FluoroPharma Medical, Inc. (OTCQB: FPMI) (“FluoroPharma”), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, announced today its CEO, Thijs Spoor, will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’sThe Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Wed, April 2, 2014
Start Time: 11:05am PDT | 12:05pm MDT | 2:05pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

About FluoroPharma Medical:

FluoroPharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. The company has licensed technology from the Massachusetts General Hospital in Boston.

The company’s goal is to enable personalized medicine through precision diagnostics that will help the medical community diagnose disease more accurately at the earliest stages, leading to more effective treatment, management and better patient outcomes.

FluoroPharma’s initial focus is the development of breakthrough PET imaging agents and is advancing two products in clinical trials for assessment of acute and chronic forms of coronary artery disease. These first in class agents have been designed to rapidly target myocardial cells. Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, agents with the potential to image brain tissue affected by Alzheimer’s disease and agents that could potentially be used for imaging specific cancers.

In addition to the United States, Europe and China, patents related to FluoroPharma’s portfolio of imaging compounds have been issued in Japan, Canada, Australia, Finland, Portugal, Ireland and Mexico.

For more information on the company, please visit: www.fluoropharma.com

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Biopharmaceutical, FluoroPharma, Public Relations, Thijs Spoor Comments Off Read more...

18 Jun

CEO Bob Spiegel of PINCH FOOD DESIGN, a Brand Based Catering Company to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 1:05 pm MDT / 2:05pm EDT on The Traders Network Show, Hosted by Michael Yorba

NEW YORK, NY–(Mar 27, 2014) – PINCH FOOD DESIGN a leading catering innovator of bold progressive food design, food quality and display concepts designed to heighten event sentiment and measurable ROI for brands, today announced that CEO Bob Spiegel will be interviewed live this afternoon by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Thursday, March 27, 2014
Start Time: 11:05am PDT | 1:05pm CDT | 2:05pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: “The Traders Network Show”
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

About PINCH FOOD DESIGN: As top-tier NYC culinary veterans with extensive experience in event catering, we believe our clients deserve a taste of something new and unpredictable, an experience that leverages the best food with never-before-seen presentation.

So we created PINCH FOOD DESIGN, a bold new brand of catering powered by a state-of-the-art kitchen and design workshop devoted solely to the creation of one-of-a-kind “food furniture.” Our intention? To impress, entertain and inspire with food as delicious as it is daring, and design as inviting as it is innovative.

Led by the groundbreaking chef/designer duo of Bob Spiegel and TJ Girard, the Pinch team is driven by an uncompromising commitment to incite, surprise, anticipation and delight with every bite; while wowing our clients — and their guests — with imaginative presentation combinations that redefine the art of celebration. To Learn more about PINCH FOOD DESIGN for corporate, wedding private and other social events visit our website atwww.pinchfooddesign.com

Or follow us at:
Facebook: https://www.facebook.com/PinchFoodDesign
Twitter: https://twitter.com/pinchfooddesign

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Bob Spiegel, Brand Based Catering, Catering, Pinch Food Design, Public Relations Comments Off Read more...

18 Jun

Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 12:05 pm MDT / 2:05pm EDT on The Traders Network Radio Show, Hosted by Michael Yorba

RICHMOND, CA–(Mar 26, 2014) – Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Wednesday, March 26, 2014
Start Time: 11:05am PDT | 12:05pm MDT | 2:05pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

About Ekso Bionics (OTCQB: EKSO)

Since 2005, Ekso Bionics (http://www.eksobionics.com) has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company’s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

Facebook: www.facebook.com/eksobionics
Twitter: @eksobionics
YouTube: http://www.youtube.com/user/EksoBionics/

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of human exoskeletons, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) the Company’s future financial performance and (iv) the assumptions underlying or relating to any statement described in points (i), (ii) or (iii) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company’s inability to obtain adequate financing, the significant length of time and resources associated with the development of our products and related insufficient cash flows and resulting illiquidity, the Company’s inability to expand the Company’s business, significant government regulation of medical devices and the healthcare industry, lack of product diversification, volatility in the price of the Company’s raw materials, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. These and other factors are identified and described in more detail in the Company’s filings with the SEC, including, the Company’s Current Report on Form 8-K filed on January 23, 2014. The Company does not undertake to update these forward-looking statements.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Ekso Bionics, Nathan Harding, Public Relations Comments Off Read more...

18 Jun

Excel Corporation Announces Formation of Medical Marijuana Merchant Processing Subsidiary — 420 Solutions, Corp

Medical Marijuana Dispensary Merchant Systems to Go Online April 1, 2014

NEW YORK, NY–(Mar 26, 2014) – Excel Corporation (OTCBB: EXCC) — a leading innovator and provider of merchant payment processing and merchant cash advance services that delivers credit/debit/prepaid card processing, mobile commerce, and related business solutions, today announced that it has created a new wholly-owned subsidiary called 420 Solutions, Corp. The primary focus of the new company is to develop and deploy advanced ways of providing payment processing services and ancillary products and services to the growing medical marijuana dispensary industry.

The announcement comes on the heels of major breakthroughs that Excel’s various subsidiary companies have had with regards to their its terminal hardware and software card processing protocols that will enable customers of medical marijuana dispensaries to use their debit cards at such locations. The new merchant services system, which is yet to be named, complies with the federal laws that have previously prevented electronic payment processers from participating in the explosive growth of the Medical Marijuana dispensary retail sector. Excel and 420 Solutions, Corp. expect to soon announce the details of a pilot program in the upcoming days once 420 Solutions, Corp. has finalized its exclusive hardware deal that will handle the new method of debit transactions at medical marijuana dispensaries.

Ruby Azrak, Excel Corp’s acting CEO and Chairman of the Board was quoted saying, “We have created a new way of allowing customers of over 2,100 Medical Marijuana dispensaries to use their debit cards at the dispensaries. This merchant segment generated over $2 billion in revenues last year, virtually none of which was done through electronic payment devices such as credit and debit cards. The market is expected to reach over $50 billion in annual sales by 2020. Excel’s 420 Solutions Processing subsidiary is committed to being the first to market with a real merchant solution for Medical Marijuana dispensaries that complies with the current federal legislation.”

About Excel Payment Systems

Excel Corporation (OTCBB: EXCC) is a leading New York City-based innovator and provider of electronic payment processing for merchants, including merchant cash advance products and services, credit/debit/prepaid card processing, mobile commerce, and related business solutions for small to medium size businesses. Excel is focused on developing innovative ways to service market segments that do not currently utilize, or which underutilize, merchant processing services.

Forward-Looking Statements:

In accordance with the Private Securities Litigation Reform Act of 1995, we caution you that, whether or not expressly stated, certain statements made in this news release that reflect management’s expectations regarding future events and economic performance are forward-looking in nature and, accordingly, are subject to risks and uncertainties. This information is qualified in its entirety by cautionary statements and risk factor disclosures contained in the Company’s Securities and Exchange Commission filings, which are available at www.sec.gov. We caution readers that certain important factors may have affected and could in the future affect the Company’s actual results and could cause the Company’s actual results for subsequent periods to differ materially from those expressed in any forward-looking statement made by or on behalf of the Company.

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Excel Corporation, Public Relations, Ruby Azrak Comments Off Read more...

18 Jun

TriStar Wellness CEO John Linderman to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:30am PDT / 12:30pm MDT / 2:30pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba

WESTPORT, CT–(Mar 25, 2014) – TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, today announced that CEO John Linderman will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Tuesday, March 25, 2014
Start Time: 11:30am PDT | 12:30pm MDT | 2:30pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

About TriStar Wellness Solutions: TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science-based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beaute de Maman™ brand of women’s health products. Additional information is available at www.tstarwellness.com.

Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like “anticipates,” “believes,” “expects,” “future,” “intends,” “plans,” and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, HemCon Medical Technologies Inc., John Linderman, Public Relations, TriStar Wellness, TriStar Wellness Solutions Inc, TWSI Comments Off Read more...

18 Jun

CEL-SCI CEO Geert Kersten to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 12:05 pm MDT / 2:05pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba

VIENNA, VA–(Mar 25, 2014) – CEL-SCI Corporation (NYSE MKT: CVM), a leading research and development company dedicated to improving the treatment of cancer and other diseases by utilizing the immune system, today announced that CEO Geert Kersten will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Tuesday, March 25, 2014
Start Time: 11:05am PDT | 12:05pm MDT | 2:05pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

About CEL-SCI: CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body’s natural defense system. Its lead investigational therapy is Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal Phase III clinical trial against head and neck cancer. CEL-SCI also has an ongoing collaboration with the US Navy to develop Multikine as a treatment against anal warts in HIV/HPV co-infected patients. CEL-SCI is further investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu, as CEL-SCI scientists are very concerned about the possible emergence of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.

For more information, please visit www.cel-sci.com.

Multikine is the trademark that CEL-SCI has registered for this investigational therapy, and this proprietary name is subject to FDA review in connection with its future anticipated regulatory submission for approval. Multikine has not been licensed or approved for sale, barter or exchange by the FDA or any other regulatory agency. Similarly, its safety or efficacy has not been established for any use. Moreover, no definitive conclusions can be drawn from the early-phase, clinical-trials data involving the investigational therapy Multikine (Leukocyte Interleukin, Injection). Further research is required, and early-phase clinical trial results must be confirmed in the well-controlled, Phase III clinical trial of this investigational therapy that is currently in progress.

When used in this release, the words “intends,” “believes,” “anticipated” and “expects” and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving necessary regulatory approvals, difficulties in manufacturing any of the Company’s potential products, inability to raise the necessary capital and the risk factors set forth from time to time in CEL-SCI Corporation’s SEC filings, including but not limited to its report on Form 10-K for the year ended September 30, 2013. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, CEL-SCI, Geert Kersten, Health, Public Relations, Research Comments Off Read more...

18 Jun

Anthony Amado Wins the Name Lottery — When Movie Character Names Affect Real World People With Same Names Survey

Character “Anthony Amado” From American Hustle Spills Over Into Real People’s Lives

NEW YORK, NY–(Mar 24, 2014) – 1800PublicRelations.com, Inc, a performance based multi-channel communications company that offers Public Relations + digital Content Marketing strategy services, announces today its short-name survey on affect movie character names have on real world people who share the same name. Over the decades we have all used blockbusters, TV shows, games and mini-series as forms of escapism from the monotony of our everyday lives, if only just for a moment. Who doesn’t enjoy a good story and fall in love or hate with the characters that Hollywood creates.

One of 2013’s biggest box office smash is Oscar nominated and Golden Globe’s “Best picture of the year” movie American Hustle.

American Hustle is a 2013 American crime comedy-drama film directed by David O. Russell, from a screenplay written by Eric Warren Singer and Russell, loosely based on the FBIABSCAM operation of the late 1970s and early 1980s. It stars Christian Bale and Amy Adamsas two con artists who are forced by an FBI agent (Bradley Cooper) to set up an elaborate sting operation on corrupt politicians. It also stars Alessandro Nivola as Anthony Amado a sleazy prosecutor. {Wikipedia}

We asked real Anthony Amados how they feel about sharing their name with this particular character and what people’s reaction when they introduces them self for the first time. Do people relate the movie’s character of Anthony Amado with them?

Anthony Amado from New Jersey was quoted saying, “It actually a great question, I went to renew my license and when the guy asked for my full name, he said, ‘Anthony Amado like from American Hustle! – That’s so cool!’ It’s kind of fun to have my name associated with a movie character and the benefit now is, no one forgets my name.”

Anthony Amado from an undisclosed area said, “The last couple of months have been insane, every time I say my name in full people ask, ‘Like from America Hustle?’ It’s strange, because up until the movie came out I was just, good old Anthony Amado, now I’m Anthony Amado! I don’t mind the reaction at all.”

Anthony Amado from California said, “To be honest, it hasn’t had that much impact on my life. Occasionally someone will comment that my name Anthony Amado is a character from American Hustle.”

Another Anthony Amado said, “To be honest I love it. Girls at bars always smile and start flirting straight away when I tell them my name is Anthony Amado. It’s as if the movie has elevated me to star status and I only share the name, luckily the sleaziness of the character hasn’t translated to the comparison. You can tell the movie was a hit, cause most people relate my name now with the movie. He is a memorable dude and look, no complaints from me if it helps with the ladies.”

As the old saying goes: any press is good press, so if you are a namesake to a villain, a super hero or even a scuzzy hustler it’s all good branding. Of course, as long as they spell your name right.

About 1800PublicRelations.com: is a performance based multi-channel communications company that offers Public Relations + digital Content Marketing strategy services. We create and deliver visibility and market awareness programs (digital, TV, radio, print) for emerging private companies, public companies and agencies worldwide. To learn more about our editorial desk or our small business public relations tools and services please visit our website at www.1800PublicRelations.com

Source: 1800PublicRelations.com Editorial Desk
Author: Matthew Bird
Co-Author: Stella Rankin

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, ABSCAM, American Hustle, Amy Adams, Anthony Amado, Movies, Public Relations Comments Off Read more...

18 Jun

BioElectronics CEO Andrew Whelan to Be Interviewed Live Wednesday on Clear Channel Business Talk Radio

Interview Scheduled at 11:30am PDT / 12:30pm MDT / 2:30pm EDT on The Traders Network Radio Show, Hosted by Michael Yorba

FREDERICK, MD–(Mar 24, 2014) – BioElectronics Corporation (PINKSHEETS:BIEL), the maker of advanced consumer medical devices, today announced that CEO Andrew Whelan will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Wednesday, March 26, 2014
Start Time: 11:30am PDT | 12:30pm MDT | 2:30pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

About The Traders Network Show — Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s “The Traders Network Show”.

About BioElectronics Corporation — BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses. For more information, please visit www.bielcorp.com.

A www.1800PublicRelations.com PR Event

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, Andrew Whelan, BioElectronics, Biophysics, Public Relations Comments Off Read more...

18 Jun

ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 12:05 pm MDT / 2:05pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba

WESTMINSTER, CO–(Mar 19, 2014) – ARCA biopharma, Inc. (NASDAQ: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that Michael R. Bristow, president and CEO, will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Date: Wednesday, March 19, 2014
Start Time: 11:05am PDT | 12:05pm MDT | 2:05pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About ARCA biopharma
ARCA biopharma is dedicated to developing genetically-targeted therapies for cardiovascular diseases. The Company’s lead product candidate, Gencaro™ (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for atrial fibrillation. ARCA has identified common genetic variations that it believes predict individual patient response to Gencaro, giving it the potential to be the first genetically-targeted atrial fibrillation prevention treatment. ARCA has a collaboration with Medtronic, Inc. for support of the GENETIC-AF trial. For more information please visitwww.arcabiopharma.com.

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

A www.1800PublicRelations.com PR Event

Safe Harbor Statement

This press release and the anticipated interview contain “forward-looking statements” for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding, potential timing for patient enrollment in the GENETIC-AF trial, the sufficiency of the Company’s capital to support its operations, the potential for genetic variations to predict individual patient response to Gencaro, Gencaro’s potential to treat atrial fibrillation, future treatment options for patients with atrial fibrillation, the role of AF burden in diagnosis and treatment of atrial fibrillation and the potential for Gencaro to be the first genetically-targeted atrial fibrillation prevention treatment. Such statements are based on management’s current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, the risks and uncertainties associated with: the Company’s financial resources and whether they will be sufficient to meet the Company’s business objectives and operational requirements; results of earlier clinical trials may not be confirmed in future trials, the protection and market exclusivity provided by the Company’s intellectual property; risks related to the drug discovery and the regulatory approval process; and, the impact of competitive products and technological changes. These and other factors are identified and described in more detail in ARCA’s filings with the SEC, including without limitation the Company’s annual report on Form 10-K for the year ended December 31, 2012, and subsequent filings. The Company disclaims any intent or obligation to update these forward-looking statements.

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800 Public Relations, ARCA biopharma, Gencaro, Michael R.Bristow, Public Relations Comments Off Read more...

Monthly Archives: June 2014 (Page 3)